Induction of specific humoral and cellular immune responses in a mouse model following gene fusion of HSP70C and Hantaan virus Gn and S0.7 in an adenoviral vector

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Cheng, Linfeng ^a   Yu, Lan ^a   Wu, Xingan ^a   Li, Kai ^a   Wang, Fang ^a   Zhang, Liang ^a   Ye, Wei ^a   Li, Puyuan ^a   Zhang, Fanglin ^a   Xu, Zhikai ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; HEAT SHOCK PROTEIN 70; HEMORRHAGIC FEVER WITH RENAL SYNDROME VACCINE; INACTIVATED VIRUS VACCINE; NUCLEOCAPSID PROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; YOUERJIAN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; EMBRYO; FEMALE; GENE FUSION; GENETIC IMMUNIZATION; HANTAVIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; VIRUS IMMUNITY; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; FEMALE; GENE FUSION; GENETIC VECTORS; GLYCOPROTEINS; HANTAAN VIRUS; HSP70 HEAT-SHOCK PROTEINS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MALE; MICE; MICE, INBRED C57BL; NUCLEOCAPSID PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; VACCINATION; VIRAL PROTEINS; VIRAL VACCINES;

EID: 84894629930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088183     Document Type: Article

References (55)

1. Schmaljohn C, Hjelle B (1997) Hantaviruses: a global disease problem. Emerg Infect Dis 3: 95-104. (Pubitemid 127431667)
2. Khaiboullina SF, Morzunov SP, St Jeor SC (2005) Hantaviruses: molecular biology, evolution and pathogenesis. Curr Mol Med 5: 773-790. (Pubitemid 43009517)
3. Kariwa H, Yoshimatsu K, Arikawa J (2007) Hantavirus infection in East Asia. Comp Immunol Microbiol Infect Dis 30: 341-356. (Pubitemid 47450088)
4. Zeier M, Handermann M, Bahr U, Rensch B, Muller S, et al. (2005) New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention-a review. Virus Genes 30: 157-180. (Pubitemid 40365061)
5. Hooper JW, Custer DM, Smith J, Wahl-Jensen V (2006) Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates. Virology 347: 208-216.
6. Hooper JW, Custer DM, Thompson E, Schmaljohn CS (2001) DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys. J Virol 75: 8469-8477. (Pubitemid 32768951)
7. Spik KW, Badger C, Mathiessen I, Tjelle T, Hooper JW, et al. (2008) Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters. Vaccine 26: 5177-5181.
8. Arikawa J, Schmaljohn AL, Dalrymple JM, Schmaljohn CS (1989) Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J Gen Virol 70 (Pt 3): 615-624. (Pubitemid 19078648)
9. Wang M, Pennock DG, Spik KW, Schmaljohn CS (1993) Epitope mapping studies with neutralizing and non-neutralizing monoclonal antibodies to the G1 and G2 envelope glycoproteins of Hantaan virus. Virology 197: 757-766.
10. Li PY, Yu L, Wu XA, Bai WT, Li K, et al. (2012) Modification of the adenoviral transfer vector enhances expression of the Hantavirus fusion protein GnS0.7 and induces a strong immune response in C57BL/6 mice. J Virol Methods 179: 90-96.
11. Schmaljohn CS, Chu YK, Schmaljohn AL, Dalrymple JM (1990) Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol 64: 3162-3170. (Pubitemid 20219517)
12. Dantas JR, Jr., Okuno Y, Asada H, Tamura M, Takahashi M, et al. (1986) Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. Virology 151: 379-384. (Pubitemid 16073451)
13. Yoshimatsu K, Yoo YC, Yoshida R, Ishihara C, Azuma I, et al. (1993) Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins. Arch Virol 130: 365-376.
14. Lindkvist M, Lahti K, Lilliehook B, Holmstrom A, Ahlm C, et al. (2007) Cross-reactive immune responses in mice after genetic vaccination with cDNA encoding hantavirus nucleocapsid proteins. Vaccine 25: 1690-1699. (Pubitemid 46108197)
15. Woo GJ, Chun EY, Kim KH, Kim W (2005) Analysis of immune responses against nucleocapsid protein of the Hantaan virus elicited by virus infection or DNA vaccination. J Microbiol 43: 537-545.
16. Van Epps HL, Schmaljohn CS, Ennis FA (1999) Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virusspecific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. J Virol 73: 5301-5308. (Pubitemid 29274811)
17. Gott P, Zoller L, Darai G, Bautz EK (1997) A major antigenic domain of hantaviruses is located on the aminoproximal site of the viral nucleocapsid protein. Virus Genes 14: 31-40. (Pubitemid 27267514)
18. Lundkvist A, Kallio-Kokko H, Sjolander KB, Lankinen H, Niklasson B, et al. (1996) Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity. Virology 216: 397-406. (Pubitemid 26083383)
19. Luo W, Zhang F, Yan Y,Wu X, Liu Y, et al. (2008) Immunological properties of a fusion protein containing nucleocapsid protein and glycoprotein Gn of Hantaan virus. Acta Virol 52: 243-249.
20. Lee HW, Lee PW, Johnson KM (1978) Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis 137: 298-308. (Pubitemid 8309146)
21. Cho HW, Howard CR, Lee HW(2002) Review of an inactivated vaccine against hantaviruses. Intervirology 45: 328-333. (Pubitemid 36173442)
22. Kruger DH, Ulrich R, Lundkvist AA (2001) Hantavirus infections and their prevention. Microbes Infect 3: 1129-1144. (Pubitemid 33044739)
23. Zhang FL, Wu XA, Luo W, Bai WT, Liu Y, et al. (2007) The expression and genetic immunization of chimeric fragment of Hantaan virus M and S segments. Biochem Biophys Res Commun 354: 858-863. (Pubitemid 46216212)
24. Li C, Liu F, Liang M, Zhang Q, Wang X, et al. (2010) Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice. Vaccine 28: 4294-4300.
25. Li J, Ye ZX, Li KN, Cui JH, Cao YX, et al. (2007) HSP70 gene fused with Hantavirus S segment DNA significantly enhances the DNA vaccine potency against hantaviral nucleocapsid protein in vivo. Vaccine 25: 239-252. (Pubitemid 44856081)
26. Kamrud KI, Hooper JW, Elgh F, Schmaljohn CS (1999) Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters. Virology 263: 209-219. (Pubitemid 29493631)
27. Hooper JW, Li D (2001) Vaccines against hantaviruses. Curr Top Microbiol Immunol 256: 171-191. (Pubitemid 32016378)
28. de Carvalho Nicacio C, Gonzalez Della Valle M, Padula P, Bjorling E, Plyusnin A, et al. (2002) Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses. J Virol 76: 6669-6677. (Pubitemid 34633533)
29. Klingstrom J, Maljkovic I, Zuber B, Rollman E, Kjerrstrom A, et al. (2004) Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge. Vaccine 22: 4029-4034. (Pubitemid 39208767)
30. Dargeviciute A, Brus Sjolander K, Sasnauskas K, Kruger DH, Meisel H, et al. (2002) Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model. Vaccine 20: 3523-3531. (Pubitemid 35248076)
31. Zheng LY, Mou L, Lin S, Lu RM, Luo EJ (2005) Enhancing DNA vaccine potency against hantavirus by co-administration of interleukin-12 expression vector as a genetic adjuvant. Chin Med J (Engl) 118: 313-319. (Pubitemid 40309639)
32. Hartl FU (1996) Molecular chaperones in cellular protein folding. Nature 381: 571-579.
33. Zhu X, Zhou P, Cai J, Yang G, Liang S, et al. (2010) Tumor antigen delivered by Salmonella III secretion protein fused with heat shock protein 70 induces protection and eradication against murine melanoma. Cancer Sci 101: 2621-2628.
34. Li XL, Sun LR, Wang Z, Sun XF (2012) The preparation of leukemia cell vaccine expressing BCG heat shock protein 70 and anti-leukemia effect in vitro. Int Immunopharmacol 14: 235-242.
35. Chen X, Tao Q, Yu H, Zhang L, Cao X (2002) Tumor cell membrane-bound heat shock protein 70 elicits antitumor immunity. Immunol Lett 84: 81-87. (Pubitemid 35248000)
36. Yu WY, Chuang TF, Guichard C, El-Garch H, Tierny D, et al. (2011) Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model. Vaccine 29: 3489-3500.
37. Li J, Li KN, Gao J, Cui JH, Liu YF, et al. (2008) Heat shock protein 70 fused to or complexed with hantavirus nucleocapsid protein significantly enhances specific humoral and cellular immune responses in C57BL/6 mice. Vaccine 26: 3175-3187.
38. Su C, Duan X, Wang X, Wang C, Cao R, et al. (2007) Heterologous expression of FMDV immunodominant epitopes and HSP70 in P. pastoris and the subsequent immune response in mice. Vet Microbiol 124: 256-263. (Pubitemid 47277487)
39. Li X, Yang X, Li L, Liu H, Liu J (2006) A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine. Vaccine 24: 3321-3331.
40. Xu Z, Wei L, Wang L, Wang H, Jiang S (2002) The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization. Biochem Biophys Res Commun 298: 552-558. (Pubitemid 35333693)
41. Razanskiene A, Schmidt J, Geldmacher A, Ritzi A, Niedrig M, et al. (2004) High yields of stable and highly pure nucleocapsid proteins of different hantaviruses can be generated in the yeast Saccharomyces cerevisiae. J Biotechnol 111: 319-333. (Pubitemid 38891718)
42. Johansson P, Olsson M, Lindgren L, Ahlm C, Elgh F, et al. (2004) Complete gene sequence of a human Puumala hantavirus isolate, Puumala Umea/hu: sequence comparison and characterisation of encoded gene products. Virus Res 105: 147-155. (Pubitemid 39207937)
43. Brun A, Albina E, Barret T, Chapman DA, Czub M, et al. (2008) Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems. Vaccine 26: 6508-6528.
44. Breloer M, Fleischer B, von Bonin A (1999) In vivo and in vitro activation of T cells after administration of Ag-negative heat shock proteins. J Immunol 162: 3141-3147. (Pubitemid 29313558)
45. Basu S, Binder RJ, Ramalingam T, Srivastava PK (2001) CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14: 303-313. (Pubitemid 32289294)
46. Castellino F, Boucher PE, Eichelberg K, Mayhew M, Rothman JE, et al. (2000) Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med 191: 1957-1964. (Pubitemid 30390357)
47. Arnold-Schild D, Hanau D, Spehner D, Schmid C, Rammensee HG, et al. (1999) Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol 162: 3757-3760. (Pubitemid 29314749)
48. Hjelle B (2002) Vaccines against hantaviruses. Expert Rev Vaccines 1: 373-384.
49. Gowen BB, Holbrook MR (2008) Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses. Antiviral Res 78: 79-90. (Pubitemid 351381175)
50. Yanagihara R, Amyx HL, Lee PW, Asher DM, Gibbs CJ, Jr., et al. (1988) Experimental hantavirus infection in nonhuman primates. Arch Virol 101: 125-130.
51. Kurata T, Tsai TF, Bauer SP, McCormick JB (1983) Immunofluorescence studies of disseminated Hantaan virus infection of suckling mice. Infect Immun 41: 391-398. (Pubitemid 13063066)
52. McKee KT, Jr., Kim GR, Green DE, Peters CJ (1985) Hantaan virus infection in suckling mice: virologic and pathologic correlates. J Med Virol 17: 107-117. (Pubitemid 16223609)
53. Ebihara H, Yoshimatsu K, Ogino M, Araki K, Ami Y, et al. (2000) Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence. J Virol 74: 9245-9255.
54. Lee PW, Yanagihara R, Gibbs CJ, Jr., Gajdusek DC (1986) Pathogenesis of experimental Hantaan virus infection in laboratory rats. Arch Virol 88: 57-66.
55. Seto T, Nagata N, Yoshikawa K, Ichii O, Sanada T, et al. (2012) Infection of Hantaan virus strain AA57 leading to pulmonary disease in laboratory mice. Virus Res 163: 284-290.